Assuming a TLF rate of 8 % at 12 months in both treatment arms and accepting 3.5 % as a margin for noninferiority , inclusion of 2,060 patients would provide more than 80 % power to detect noninferiority of the biodegradable polymer SES compared with the durable polymer EES at a 1-sided type I error of 0.05 .